The sad story of Vioxx, and what we should learn f...[Cleve Clin J Med. 2004] - PubMed Result

Search for

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Cleve Clin J Med. 2004 Dec;71(12):933-4, 936, 938-9.Links

The sad story of Vioxx, and what we should learn from it.

Karha J, Topol EJ.

Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.

PMID: 15641522 [PubMed - indexed for MEDLINE]

Related Articles

The Vioxx debacle. [IEEE Eng Med Biol Mag. 2005]
Evaluating drug effects in the post-Vioxx world: there must be a better way. [Circulation. 2006]
Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs. [Circulation. 2006]
Despite warnings, drug giant took long path to Vioxx recall. [NY Times (Print). 2004]
COX-2 inhibitor use after Vioxx: careful balance or end of the rope? [Am J Manag Care. 2004]
» See all Related Articles...

Display Show